Press kit , Virelion

Company intro · ~1:18

Brand identity

Name. Virelion · Virelion Biotech
Tagline. Engineering the heart
Positioning. Computational cardiac regeneration , research-stage. Compute first, lab second.

Four pillars. Gene therapy (VB-101) · Scaffold & biomaterials (VB-204) · Protein & drug discovery · Computational platform (VB-310 / HeartTwin)

Color. Blood #5c0a14 · Deep #3d0610 · Tint #f3e9eb · Ink #111 · Off-white #f6f4f4 · White #fff

Type. Newsreader for display and the italic wordmark · Inter for UI and body

Mark. Lion-brain circular logo on light ground; use logo-nav.png in UI, logo-sm.png where space is tight. Prefer the mark + “Virelion” wordmark in Newsreader italic.

Voice. Precise and evidence-first. State research stage plainly. Do not imply approved therapies, clinical decision support, or SaMD. Do not co-brand with other companies or reuse their visual systems.

Do not. Generic stock photography as the sole identity · clinical overclaim · competitor color systems or layouts presented as Virelion’s · third-party company names or visual systems in code, assets, or copy

Boilerplate

Virelion Biotech is a research-stage company in computational cardiac regeneration. Work spans four pillars , gene therapy, scaffold & biomaterials, protein & drug discovery, and an open computational platform centered on HeartTwin , with measurement and evaluation tools released in public repositories.

Assets

Logo (nav)